PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
23.03
-1.06 (-4.40%)
At close: Apr 28, 2026, 4:00 PM EDT
23.16
+0.13 (0.56%)
After-hours: Apr 28, 2026, 5:55 PM EDT
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for PROCEPT BioRobotics stock have an average target of 35.44, with a low estimate of 20 and a high estimate of 62. The average target predicts an increase of 53.89% from the current stock price of 23.03.
Analyst Consensus: Buy
* Price targets were last updated on Mar 6, 2026.
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Initiates $30 | Hold | Initiates | $30 | +30.26% | Mar 6, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $47 → $30 | Strong Buy | Maintains | $47 → $30 | +30.26% | Mar 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $55 → $30 | Buy | Maintains | $55 → $30 | +30.26% | Feb 26, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $50 → $34 | Strong Buy | Maintains | $50 → $34 | +47.63% | Feb 26, 2026 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 26, 2026 |
Financial Forecast
Revenue This Year
404.61M
from 308.05M
Increased by 31.34%
Revenue Next Year
503.81M
from 404.61M
Increased by 24.52%
EPS This Year
-1.57
from -1.72
EPS Next Year
-0.93
from -1.57
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 424.3M | 546.0M | |||
| Avg | 404.6M | 503.8M | |||
| Low | 378.1M | 454.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 37.7% | 34.9% | |||
| Avg | 31.3% | 24.5% | |||
| Low | 22.7% | 12.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.43 | -0.67 | |||
| Avg | -1.57 | -0.93 | |||
| Low | -1.65 | -1.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.